Supporting Organization
2 years as a CAC2 member Member since 2025
- Location
- Atlanta, GA
To transform the lives of patients by advancing innovative therapies that target MYC-driven diseases, starting with pediatric high-risk neural tumors. Through cutting-edge science and a commitment to addressing unmet medical needs, we aim to restore hope and deliver life-changing solutions globally.
How Dimer Pharmaceuticals focuses its efforts
- 5%Advocacy
- 5%Family Support
- 15%Research Funding
- 5%Survivorship
- 70%Drug development